CEO and Vice-chairperson, LG Chem
Anthony Wallace/AFP/Getty Images
Danny Yeung’s vision of helping people proactively manage their health finally came to life last year with the launch of CircleDNA, his company’s first direct to consumer DNA testing kit.
Genetic testing and digital health company Prenetics began life in 2014 as a side project for a group of university professors. Initially focused on prenatal genetic screening for expectant mothers, under the leadership of Yeung the company broadened its offering, first with tests sold only to medical professionals.
"The future of healthcare is prevention, not treatment." Yeung told Business Insider. "With the most advanced DNA and diagnostics technology, our mission is to give everyone the power to be in control of their own health. From genetics to playing a major role in the fight against COVID-19, we are proud to serve."
In late 2018, the company stepped up its ambition when it formed a joint venture with China’s leading clinical genomics testing company Berry Genomics, which would open the huge mainland China market to Prenetics’ products.
Prenetics' potential has not gone unnoticed by investors. To date the company has attracted up to $50 million in funding from a variety of investors, including Alibaba.
Prenetics is not Yeung’s first experience in the startup world. In his late 20s he was involved in a number of ventures, including an F&B franchising business and a company selling hospitality furniture. In 2010 he founded a group buying platform uBuyiBuy in Hong Kong, which was bought over just six months later by GroupOn.